Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-13 5:54 pm Purchase |
2024-09-11 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 555,736,060 75.200% |
379,871,779 (+216.00%) |
Filing History |
| 2023-03-13 4:51 pm Purchase |
2023-03-08 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 36,882,393 5.270% |
31,399,111 (+572.63%) |
Filing History |
| 2023-02-16 4:01 pm Unchanged |
2023-02-07 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 175,864,281 78.100% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 0 0.000% |
-6,295,713 (Position Closed) |
Filing History |
| 2022-12-09 5:24 pm Purchase |
2022-12-06 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 175,864,281 81.800% |
9,346,434 (+5.61%) |
Filing History |
| 2022-08-18 4:43 pm Purchase |
2022-08-16 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 166,517,847 81.150% |
94,870,338 (+132.41%) |
Filing History |
| 2022-02-14 10:47 am Purchase |
2021-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 6,295,713 6.400% |
495,713 (+8.55%) |
Filing History |
| 2021-05-14 4:27 pm Purchase |
2021-05-12 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 71,647,509 70.780% |
11,365,921 (+18.85%) |
Filing History |
| 2021-04-22 5:11 pm Unchanged |
2021-04-20 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.370% |
0 (Unchanged) |
Filing History |
| 2021-03-26 5:07 pm Unchanged |
2021-03-24 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.370% |
0 (Unchanged) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 5,800,000 7.050% |
5,800,000 (New Position) |
Filing History |
| 2020-11-25 4:11 pm Purchase |
2020-11-22 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,483,282 6.580% |
3,323 (+0.06%) |
Filing History |
| 2020-11-10 4:20 pm Purchase |
2020-11-06 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,479,959 6.580% |
149,701 (+2.81%) |
Filing History |
| 2020-11-10 4:11 pm Purchase |
2020-11-06 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.940% |
4,341,317 (+7.76%) |
Filing History |
| 2020-10-06 7:28 pm Purchase |
2020-10-02 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 55,940,271 69.110% |
9,730,539 (+21.06%) |
Filing History |
| 2020-09-28 4:40 pm Purchase |
2020-09-18 | 13D | Summit Therapeutics Inc. SMMT |
Zanganeh Mahkam | 5,330,258 7.800% |
5,330,258 (New Position) |
Filing History |
| 2020-09-28 4:37 pm Purchase |
2020-09-18 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 46,209,732 64.890% |
46,209,732 (New Position) |
Filing History |
| 2020-06-17 2:38 pm Sale |
2020-06-12 | 13D | Summit Therapeutics Inc. SMMT |
LANSDOWNE PARTNERS (UK) LLP | 13,664,880 4.060% |
-4,006,035 (-22.67%) |
Filing History |
| 2020-05-15 10:18 am Sale |
2020-05-08 | 13D | Summit Therapeutics Inc. SMMT |
LANSDOWNE PARTNERS (UK) LLP | 17,670,915 5.260% |
-3,472,585 (-16.42%) |
Filing History |